Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Prophylactic Magnesium Use in Pregnant Women on Reversal of Neuromuscular Block With Sugammadex:Evaluation With TOF

NCT05558969 is registered in ClinicalTrials.gov with Eskisehir Osmangazi University as lead sponsor.

NCT NCT05558969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Prophylactic Magnesium Use in Pregnant Women on Reversal of Neuromuscular Block With Sugammadex:Evaluation With TOF
Lead sponsor
Eskisehir Osmangazi University
Phase
Not applicable
Overall status
Completed
Start date
September 28, 2022
Completion date
May 26, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

magnesium sulfate, neuromuscular blockade, pregnancy; pre-eclampsia